Published 2 months ago • loading... • Updated 2 months ago

Bayer adds $1.37 billion to Roundup litigation reserves, raises 2025 sales forecast

Summary by KULR-TV

German pharmaceutical and agricultural chemicals giant Bayer said it had put aside an extra 1.2 billion euros ($1.4 billion) to deal with long-running US legal woes linked to a weedkiller.

35 Articles

Sueddeutsche Zeitung

Lean Left

Bayer: Provisions and Revenue Forecast Rise

Bayer has raised its forecast and plans additional provisions of 1.7 billion euros for litigation in the US, especially because of glyphosate. Despite the challenges, the Group is showing positive developments in the pharmaceutical sector.

2 months ago·Munich, Germany

Read Full Article

RTÉ

Center

Bayer adds $1.37 billion to Roundup litigation reserves

German pharmaceutical and biotechnology group Bayer said today it had set aside an additional €1.2 billion in provisions to address ongoing litigation in the US over weed killer Roundup.

2 months ago·Ireland

Read Full Article

Liberation

Lean Left

Glyphosate: Bayer Increases Provisions for Litigation

The company that produces this herbicide, which is the subject of numerous controversy and judicial interference, is preparing to be brought to justice again.

2 months ago·Paris, France

Read Full Article

Newsbug.info

+29 Reposted by 29 other sources

Center

Bayer sets aside more cash to deal with weedkiller woes

German pharmaceutical and agricultural chemicals giant Bayer said it had put aside an extra 1.2 billion euros ($1.4 billion) to deal with long-running US legal woes linked to a weedkiller.

2 months ago

Read Full Article

Barron's

Center

Bayer Sets Aside More Cash To Deal With Weedkiller Woes

German pharmaceutical and agricultural chemicals giant Bayer said it had put aside an extra 1.2 billion euros ($1.4 billion) to deal with long-running US legal woes linked to a weedkiller.

2 months ago·New York, United States

Read Full Article

manager magazin

Bayer: Pharmaceutical Company Raises Sales Targets and Sets Aside Billions More for Us Lawsuits

The pharmaceutical company Bayer has raised its sales and earnings forecast for the full year. However, CEO Bill Anderson has also had to set aside an additional €1.7 billion due to the glyphosate trials in the USA.

2 months ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year